Key facts
- This page summarizes Robert A. Kleczynski's Form 4 filing for EXELON CORP (EXC).
- 12 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2026, 16:27.
Robert A. Kleczynski - 02 Feb 2026 Form 4 Insider Report for EXELON CORP (EXC)
- Reporting relationship
- SVP, Controller & Tax
- Issuer ticker
- EXC
- Reported as of
- 02 Feb 2026
- Net transaction value
- -$383,378
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2026, 16:27:14 UTC
- Prior SEC filing
- 26 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- David T Skinner, attorney-in-fact for Robert A Kleczynski
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert A. Kleczynski filed Form 4 for EXELON CORP (EXC) on 04 Feb 2026.
Change
- Previous filing in this sequence was filed on 26 Feb 2025.
- Current net transaction value: -$383,378.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001982165
Primary reporting owner
Kleczynski Robert A
- Relationship
- SVP, Controller & Tax
- Address
- 10 S DEARBORN STREET, 54TH FLOOR, CHICAGO
- Signature
- David T Skinner, attorney-in-fact for Robert A Kleczynski
- Signature date
- 04 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,474
- Change %
- +3.6%
- Price
- Shares after
- 42,599
- Date
- 02 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
EXC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,684
- Change %
- +4%
- Price
- Shares after
- 44,283
- Date
- 02 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
EXC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,110
- Change %
- +4.8%
- Price
- Shares after
- 46,393
- Date
- 02 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
EXC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +7,019
- Change %
- +15%
- Price
- Shares after
- 53,412
- Date
- 02 Feb 2026
- Ownership
- Direct
- Footnotes
- F2
EXC
transaction
Common Stock
Tax liability
- Transaction value
- $165,453
- Shares
- -3,768
- Change %
- -7.1%
- Price
- $43.91
- Shares after
- 49,644
- Date
- 02 Feb 2026
- Ownership
- Direct
EXC
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $217,925
- Shares
- -4,963
- Change %
- -10%
- Price
- $43.91
- Shares after
- 44,681
- Date
- 02 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXC
transaction
Derivative
2023 Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -1,474
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 02 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,474
- Exercise price
- Footnotes
- F1, F3
EXC
transaction
Derivative
2024 Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -1,684
- Change %
- -50%
- Price
- Shares after
- 1,683
- Date
- 02 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,684
- Exercise price
- Footnotes
- F1, F4
EXC
transaction
Derivative
2025 Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -2,110
- Change %
- -33%
- Price
- Shares after
- 4,218
- Date
- 02 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,110
- Exercise price
- Footnotes
- F1, F5
EXC
transaction
Derivative
2026 Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +5,673
- Change %
- Price
- $0.000000
- Shares after
- 5,673
- Date
- 02 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,673
- Exercise price
- Footnotes
- F1
EXC
transaction
Derivative
2023-2025 Performance Shares
Award
- Transaction value
- $0
- Shares
- +7,019
- Change %
- Price
- $0.000000
- Shares after
- 7,019
- Date
- 02 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,019
- Exercise price
- Footnotes
- F2
EXC
transaction
Derivative
2023-2025 Performance Shares
Options Exercise
- Transaction value
- Shares
- -7,019
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 02 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,019
- Exercise price
- Footnotes
- F2
EXC
holding
Derivative
Deferred phantom share equivalents
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,798
- Date
- 02 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,798
- Exercise price
- Footnotes
- F6, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Restricted stock unit (RSU) award granted under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Talent Management and Compensation Committee (TMCC) with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award.
Footnote F2
Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the TMCC's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the LTIP's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date.
Footnote F3
Balance at the time of this vesting includes 53 additional shares acquired through automatic dividend reinvestment during 2025.
Footnote F4
Balance at the time of this vesting includes 121 additional shares acquired through automatic dividend reinvestment during 2025.
Footnote F5
Balance at the time of this vesting includes 227 additional shares acquired through automatic dividend reinvestment during 2025.
Footnote F6
Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.
Footnote F7
Balance as of 12/31/2025 and includes 62 phantom share equivalents accrued during 2025 through automatic dividend reinvestment.